Victoza has been shown in several trials to be superior (not just non inferior) to several other diabetes medication. It is really taking market share. This is also being studied at a higher dose of 3 mg for use in obesity and is currently in phase 3 trials as Liraglutide 3 mg (NN8022). This stupid site won't let me post a link, but just look for it in the R&D pipeline page of Novo Nordisk's website.
Sentiment: Hold